Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Kobayashi Pharmaceutical Co., Ltd.    4967   JP3301100008

KOBAYASHI PHARMACEUTICAL CO., LTD.

(4967)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Kobayashi Pharmaceutical : Change in Fiscal Year (Closing date of business year)

share with twitter share with LinkedIn share with facebook
02/12/2016 | 03:55am EDT

854f3140-a905-4998-b06d-0a3089d73038.pdf



January 25, 2016


Change in Fiscal Year (closing date of business year)


In the meeting of the Board of Directors held today, January 25, 2016, it was resolved that the fiscal year (closing date of business year) of Kobayashi Pharmaceutical Co., Ltd. be changed as follows, subject to approval by the shareholders of the agenda item, "Partial Revision of the Articles of Association," in the general meeting of shareholders for the 98th business year to be held in the middle of June 2016.


  1. Reason for the Change


    To continue the growth of the international business of the Kobayashi Group in the future, it is essential for the parent company to adopt the same fiscal year used by its consolidated subsidiaries in the international market in order to globalize and improve the efficiency of its business management.


  2. Fiscal Year after Change


    Current fiscal year: April 1 to March 31 of the following year (closed on March 31) After change: January 1 to December 31 (closed on December 31)


    As a transitional measure, the next fiscal year (99th business year of the Company) will be the nine months starting on April 1, 2016 and closing on December 31, 2016.


  3. Future Schedule


Forecasts of performance for the year ending December 31, 2016 (99th business year) will be announced in the Summary of Financial Statements for the Year ending March 31, 2016, which will be published in May 2016.

Kobayashi Pharmaceutical Co. Ltd. issued this content on 25 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 February 2016 08:54:20 UTC

Original Document: http://www.kobayashi.co.jp/english/company/news/pdf/160125.pdf


share with twitter share with LinkedIn share with facebook
All news about KOBAYASHI PHARMACEUTICAL CO., LTD.
06/29KOBAYASHI PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
FA
2019KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2019KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2018KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2018KOBAYASHI PHARMACEUTICAL CO LTD : quaterly earnings release
2018KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2017KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2017KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2017KOBAYASHI PHARMACEUTICAL : Notice Concerning Proxy Voting Policy in The Kobayash..
PU
2016KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2020 157 B 1 497 M 1 497 M
Net income 2020 19 386 M 185 M 185 M
Net cash 2020 93 309 M 891 M 891 M
P/E ratio 2020 40,2x
Yield 2020 0,76%
Capitalization 778 B 7 423 M 7 426 M
EV / Sales 2020 4,37x
EV / Sales 2021 4,10x
Nbr of Employees 3 435
Free-Float 62,2%
Chart KOBAYASHI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kobayashi Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KOBAYASHI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 9 075,71 JPY
Last Close Price 9 950,00 JPY
Spread / Highest target 9,55%
Spread / Average Target -8,79%
Spread / Lowest Target -24,6%
EPS Revisions
Managers
NameTitle
Akihiro Kobayashi President & Representative Director
Kazumasa Kobayashi Chairman
Noriaki Hirao Manager-Finance & Accounting
Haruo Tsuji Independent Outside Director
Satoshi Yamane Senior MD & Senior GM-Group Headquarters
Sector and Competitors
1st jan.Capitalization (M$)
KOBAYASHI PHARMACEUTICAL CO., LTD.7.34%7 597
THE PROCTER & GAMBLE COMPANY13.25%350 740
UNILEVER N.V.0.57%160 243
THE ESTÉE LAUDER COMPANIES INC.12.63%84 024
HINDUSTAN UNILEVER LIMITED11.48%69 511
COLGATE-PALMOLIVE COMPANY15.18%67 983